Ameriprise Financial Inc. increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 56.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 270,042 shares of the company's stock after acquiring an additional 97,329 shares during the period. Ameriprise Financial Inc. owned about 0.31% of HealthEquity worth $25,911,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Pier Capital LLC bought a new stake in shares of HealthEquity in the fourth quarter valued at $8,024,000. HighTower Advisors LLC boosted its position in HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock valued at $9,122,000 after buying an additional 4,370 shares during the period. Wells Fargo & Company MN lifted its stake in HealthEquity by 4.7% in the fourth quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock worth $11,988,000 after acquiring an additional 5,594 shares during the period. Geneva Capital Management LLC raised its stake in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after buying an additional 206,894 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of HealthEquity by 2.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock valued at $104,280,000 after buying an additional 25,004 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.
HealthEquity Stock Performance
Shares of HQY stock traded up $0.54 on Tuesday, hitting $98.14. The company had a trading volume of 117,650 shares, compared to its average volume of 985,075. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.49 billion, a P/E ratio of 90.04, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The company has a 50-day moving average price of $87.92 and a 200-day moving average price of $97.20. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.
Wall Street Analyst Weigh In
HQY has been the subject of several recent analyst reports. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Barrington Research reissued an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, April 11th. Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. KeyCorp decreased their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Finally, The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $111.75.
Check Out Our Latest Report on HQY
Insider Buying and Selling
In other news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares of the company's stock, valued at $6,597,842.85. This trade represents a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
